220 related articles for article (PubMed ID: 32279432)
1. Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation.
Cai X; Zheng S; Liu Y; Zhang Y; Lu J; Huang Y
Liver Int; 2020 Jul; 40(7):1594-1600. PubMed ID: 32279432
[TBL] [Abstract][Full Text] [Related]
2. A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation.
Zhou BG; Ju SY; Mei YZ; Jiang X; Wang M; Zheng AJ; Ding YB
Front Endocrinol (Lausanne); 2023; 14():1160532. PubMed ID: 37476492
[TBL] [Abstract][Full Text] [Related]
3. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.
Mantovani A; Dauriz M; Sandri D; Bonapace S; Zoppini G; Tilg H; Byrne CD; Targher G
Liver Int; 2019 Apr; 39(4):758-769. PubMed ID: 30657626
[TBL] [Abstract][Full Text] [Related]
4. The association of non-alcoholic fatty liver disease and atrial fibrillation: a review.
Käräjämäki AJ; Hukkanen J; Ukkola O
Ann Med; 2018 Aug; 50(5):371-380. PubMed ID: 29929399
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease.
Cai X; Sun L; Liu X; Zhu H; Zhang Y; Zheng S; Huang Y
Ther Adv Chronic Dis; 2021; 12():20406223211024361. PubMed ID: 34249302
[TBL] [Abstract][Full Text] [Related]
6. The monocyte-to-high-density lipoprotein ratio is associated with the occurrence of atrial fibrillation among NAFLD patients: A propensity-matched analysis.
Wang L; Zhang Y; Yu B; Zhao J; Zhang W; Fan H; Ren Z; Liang B
Front Endocrinol (Lausanne); 2023; 14():1127425. PubMed ID: 37056665
[TBL] [Abstract][Full Text] [Related]
7. Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults.
Roh JH; Lee JH; Lee H; Yoon YH; Kim M; Kim YG; Park GM; Park JH; Seong IW
Liver Int; 2020 Feb; 40(2):338-346. PubMed ID: 31479572
[TBL] [Abstract][Full Text] [Related]
8. Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis.
Jaiswal V; Ang SP; Huang H; Momi NK; Hameed M; Naz S; Batra N; Ishak A; Doshi N; Gera A; Sharath M; Waleed MS; Raj N; Aguilera Alvarez VH
J Investig Med; 2023 Aug; 71(6):591-602. PubMed ID: 37002665
[TBL] [Abstract][Full Text] [Related]
9. Interatrial septal fat thickness and left atrial stiffness are mechanistic links between nonalcoholic fatty liver disease and incident atrial fibrillation.
Mahfouz RA; Gouda M; Galal I; Ghareb MS
Echocardiography; 2019 Feb; 36(2):249-256. PubMed ID: 30548700
[TBL] [Abstract][Full Text] [Related]
10. Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).
Käräjämäki AJ; Pätsi OP; Savolainen M; Kesäniemi YA; Huikuri H; Ukkola O
PLoS One; 2015; 10(11):e0142937. PubMed ID: 26571029
[TBL] [Abstract][Full Text] [Related]
11. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Alon L; Corica B; Raparelli V; Cangemi R; Basili S; Proietti M; Romiti GF
Eur J Prev Cardiol; 2022 May; 29(6):938-946. PubMed ID: 34939092
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study.
Lee SR; Han KD; Choi EK; Oh S; Lip GYH
Sci Rep; 2021 Feb; 11(1):3737. PubMed ID: 33580177
[TBL] [Abstract][Full Text] [Related]
14. The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index.
Park HE; Lee H; Choi SY; Kim HS; Chung GE
Sci Rep; 2020 Mar; 10(1):5023. PubMed ID: 32193478
[TBL] [Abstract][Full Text] [Related]
15. The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis.
Wijarnpreecha K; Boonpheng B; Thongprayoon C; Jaruvongvanich V; Ungprasert P
Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):525-532. PubMed ID: 28866089
[TBL] [Abstract][Full Text] [Related]
16. Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study.
Long MT; Yin X; Larson MG; Ellinor PT; Lubitz SA; McManus DD; Magnani JW; Staerk L; Ko D; Helm RH; Hoffmann U; Chung RT; Benjamin EJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28465298
[TBL] [Abstract][Full Text] [Related]
17. Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
Kang MK; Park JG; Kim MC
Yonsei Med J; 2020 Oct; 61(10):860-867. PubMed ID: 32975060
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Bisaccia G; Ricci F; Khanji MY; Sorella A; Melchiorre E; Iannetti G; Galanti K; Mantini C; Pizzi AD; Tana C; Renda G; Fedorowski A; De Caterina R; Gallina S
Curr Probl Cardiol; 2023 Jun; 48(6):101643. PubMed ID: 36773944
[TBL] [Abstract][Full Text] [Related]
19. Impact of Nonalcoholic Fatty Liver Disease on Arrhythmia Recurrence Following Atrial Fibrillation Ablation.
Donnellan E; Cotter TG; Wazni OM; Elshazly MB; Kochar A; Wilner B; Patel D; Kanj M; Hussein A; Baranowski B; Cantillon D; Griffin B; Jaber W; Saliba WI
JACC Clin Electrophysiol; 2020 Oct; 6(10):1278-1287. PubMed ID: 33092755
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes.
Targher G; Mantovani A; Pichiri I; Rigolon R; Dauriz M; Zoppini G; Morani G; Vassanelli C; Bonora E
Clin Sci (Lond); 2013 Sep; 125(6):301-9. PubMed ID: 23596966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]